SK-II in China
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble will resume sales of its SK-II skin care and cosmetics brand in mainland China in coming weeks, firm announces Oct. 24. The decision was made following an announcement by Chinese health authorities regarding the safety of the products. "We are deeply gratified by the clarification regarding SK-II product safety by relevant authoritative government organizations," P&G says. "SK-II always puts product safety and quality first and we always endeavor to strictly abide by the laws and regulations in China." P&G suspended sales of SK-II in Sept. 22 after inspection authorities detected the presence of heavy metals in products (1"The Rose Sheet" Oct. 2, 2006, p. 4)...
You may also be interested in...
P&G Skin, Hair, Fragrance Categories Grow Double Digits In Q3
Procter & Gamble's skin-care, hair-care and prestige-fragrance categories achieved double-digit revenue growth during the third quarter (ended March 31), fueling 8 percent growth in the beauty division, the firm said during a May 1 analyst call
P&G Suspends SK-II Sales in China Over Impurities Uproar
Procter & Gamble is suspending sales of its SK-II skin care and cosmetics brand in mainland China until authorities there clarify their stance in regards to the detection of certain impurities in the line
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”